Skip to main content

Peer Review reports

From: Randomized and dose-escalation trials of recombinant human serum albumin /granulocyte colony-stimulating factor in patients with breast cancer receiving anthracycline-containing chemotherapy

Original Submission
8 Feb 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
12 Mar 2021 Author responded Author comments - Binghe Xu
5 Mar 2021 Reviewed Reviewer Report
7 Mar 2021 Reviewed Reviewer Report - Tadahiko Shien
Resubmission - Version 3
12 Mar 2021 Submitted Manuscript version 3
Publishing
23 Mar 2021 Editorially accepted
31 Mar 2021 Article published 10.1186/s12885-021-08093-z

You can find further information about peer review here.

Back to article page
\